1/99
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No study sessions yet.
Kotov et al., 2021
Reviews the HiTOP model framework, supporting evidence, and limitations of the DSM.
Forbes et al., 2023
Fried et al., 2017
Southward et al., 2023
Rodriguez-Seijas et al., 2023
Brownlow, 2023
Hall et al., 2016
MDD DSM-5-TR dx criteria
Hollon et al., 2021
Monroe & Harkness, 2022
Rottenberg, 2017
Culverhouse, 2017
GAD DSM-5-TR dx criteria
Newman & Llera, 2011
PTSD DSM-5-TR dx criteria
Bryant, 2019
Brewin et al., 2017
Haslam, 2016
SAD DSM-5-TR dx criteria
Ginat-Frolich et al., 2024
Krieg & Xu, 2015
Bainbridge et al., 2022
Panic disorder DSM-5-TR dx criteria
Agoraphobia DSM-5-TR dx criteria
Robinaugh et al., 2019
Naragon-Gainey et al., 2010
OCD DSM-5-TR dx criteria
Abramowitz & Jacoby, 2015
Asher et al., 2020
Anorexia Nervosa DSM-5-TR dx criteria
Forbush et al (in press)
Walsh et al., 2023
Johnson-Munguia et al., 2024
Bulimia Nervosa DSM-5-TR dx criteria
Binge Eating Disorder DSM-5-TR dx criteria
Stice, 2016
Nagata et al., 2020
Brown & Keel, 2023
BPD DSM-5-TR dx criteria
Crowell et al., 2009
Southward & Cheavens, 2018
Rodriguez-Seijas et al., 2024
Bullis et al., 2019
Histrionic PD DSM-5-TR dx criteria
Narcissistic PD DSM-5-TR dx criteria
Miller et al., 2021
Miller et al., 2022
Conduct Disorder DSM-5-TR dx criteria
Oppositional Defiant Disorder DSM-5-TR dx criteria
Beauchaine & McNulty, 2013
Beauchaine et al., 2010
Frick et al., 2014
Antisocial PD DSM-5-TR dx criteria
Beauchaine et al., 2009
Wright et al., 2022
Muris et al., 2017
Intermittent Explosive Disorder DSM-5-TR dx criteria
Coccaro, 2012
Wakefield, 2016
ADHD DSM-5-TR dx criteria
Hinshaw, 2018
Faraone et al., 2021
Nigg, 2017
Substance-Related Disorders DSM-5-TR dx criteria
Boness et al., 2021
Watts et al., 2021
Watts et al., 2023
Grant et al., 2010
OCPD DSM-5-TR
Diedrich & Voderholzer, 2015
Limburg et al., 2017
Samuel et al., 2022
Avoidant PD DSM-5-TR dx criteria
Lampe, 2016
Hummelen et al., 2022
De Fruyt & de Clercq, 2014
Paranoid PD DSM-5-TR dx criteria
Fanti et al., 2023
Samuel & Widiger, 2008
d’Huart et al., 2023
Schizoid PD DSM-5-TR dx criteria
Schizotypal PD DSM-5-TR dx criteria
Kendler, 1985
Raine, 2006
Schizophrenia DSM-5-TR dx criteria
Andreou et al., 2023
Kotov et al., 2024
Torrey, 2024
Bipolar I Disorder DSM-5-TR dx criteria
Sigitova et al., 2017
Sperry et al., 2017
Sperry et al., 2024
Bipolar II disorder DSM-5-TR dx criteria
HiTOP model
AMPD model
How do the categorical, dimensional, and network models of psychopathology differ from one another?
DSM limitations (Kotov, 2021)
• Unsupported Categorical Assumption: Traditional systems assume mental disorders are discrete categories, but extensive research finds continuity between psychopathology and normality.
• Poor Reliability and Stability: Categorical diagnoses demonstrate low stability over time and low agreement between diagnosticians, leading to a loss of information.
• Excessive Comorbidity: The co-occurrence of multiple disorders is extremely common, complicating research and clinical decision-making. Traditional systems treat disorders as independent conditions, failing to account for their shared features.
• Diagnostic Heterogeneity: Many traditional diagnoses group together symptoms that have little in common, creating highly heterogeneous patient groups.
• Prevalence of Unspecified Diagnoses: A significant number of patients who need care do not meet the full criteria for any specific disorder and receive an uninformative "Other Specified/Unspecified" diagnosis.
HiTOP core principles (Kotov, 2021)
1. Dimensionality: Psychopathology is best described by dimensions, improving reliability and fully characterizing every individual's standing on each construct. While the model is primarily dimensional, it remains open to evidence of discrete, categorical entities if they are identified.
2. Co-occurrence: The classification is built by grouping related signs and symptoms into coherent dimensions, which addresses the problem of diagnostic heterogeneity.
3. Hierarchy: The model arranges dimensions from narrow to broad, accounting for comorbidity. Higher-order dimensions represent the shared features among more specific conditions, allowing comorbidity to be measured and studied directly.
HiTOP structure (Kotov, 2021)
• Superspectra: The highest level includes broad factors like the general psychopathology p factor. Hypothesized superspectra include emotional dysfunction, psychosis, and externalizing.
• Spectra: Six major spectra have been identified: Internalizing, Thought Disorder, Disinhibited Externalizing, Antagonistic Externalizing, Detachment, and Somatoform (provisional).
• Subfactors: Spectra are composed of clusters of syndromes, such as Fear and Distress within the Internalizing spectrum.
• Syndromes: These are dimensional constructs composed of closely related components (e.g., social anxiety).
• Symptom Components and Maladaptive Traits: The most specific level, comprising over 100 proposed dimensions like performance anxiety, separation insecurity, and anhedonia.